Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.